9 reports

SEDATION IS OFTEN ACHIEVED USING A BENZODIAZEPINE, IN COMBINATION WITH AN OPIOID FOR PAIN RELIEF AND A BARBITURATE-LIKE HYPNOTIC AGENT IF DEEPER SEDATION IS REQUIRED.

  • Colorectal Cancer
  • Arthrex, Inc.
  • Boston Scientific Corporation
  • EndoChoice, Inc.
  • FUJIFILM Holdings Corporation

The analgesic effect was also statistically significant for total pain relief over three, eight, twelve and ## hours post dose.

  • Biopharmaceutical
  • Colorectal Cancer
  • United States
  • Product Initiative
  • BioPharma company

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Cancer
  • Colorectal Cancer
  • United States
  • Product Initiative
  • Novartis AG

These submissions were based on clinical trials that showed gouty arthritis patients treated with ACZ## at the time of an attack experienced superior pain relief at ## hours and a significant reduction in the risk of new attacks over six months, compared to patients treated with the inject

  • Colorectal Cancer
  • Monoclonal Antibody
  • World
  • Product Initiative
  • XBiotech Inc.

Exelixis, Inc. reported interim data on pain relief and related reduction in narcotic analgesic use with cabozantinib in castration-resistant prostate cancer (CRPC) patients with bone metastases.

  • Colorectal Cancer
  • Therapy
  • United States
  • Product Initiative
  • Exelixis, Inc.
  • METASTATIC COLORECTAL CANCER - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2016

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Biotech
  • Colorectal Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.

THE COMPANY OFFERS OVER-THE-COUNTER (OTC) PRODUCTS FOR PAIN RELIEF, ORAL HEALTH, NUTRITION, SKIN HEALTH AND RESPIRATORY DISEASES.

  • Colorectal Cancer
  • Hospital
  • Monoclonal Antibody
  • Targeted Therapy
  • GlaxoSmithKline plc
  • COLORECTAL CANCER - PIPELINE BY GILEAD SCIENCES INC

THE COMPANY OFFERS OVER-THE-COUNTER (OTC) PRODUCTS FOR PAIN RELIEF, ORAL HEALTH, NUTRITION, SKIN HEALTH AND RESPIRATORY DISEASES.

  • Cancer
  • Colorectal Cancer
  • United States
  • Product Initiative
  • Merck & Co., Inc.

Exelixis, Inc. reported interim data on pain relief and related reduction in narcotic analgesic use with cabozantinib in castration-resistant prostate cancer (CRPC) patients with bone metastases.

  • Biotech
  • Colorectal Cancer
  • United States
  • Company
  • Product Initiative